Brisbane researchers harnessing Artificial Intelligence to accurately predict effectiveness of cancer treatments
Predicting treatment responses in cancer patients and using artificial intelligence to ensure accurate radiology reporting are on track to become a reality with the assistance of Commonwealth funding.
The announcement about predictive testing approaches, with an aim to commercialise analysis tools to enhance cancer patient outcomes, was made by Assistant Minster for Science, Jobs and Innovation, Zed Seselja, and Federal Member for Brisbane, Trevor Evans.
Led by Brisbane company Max Kelsen Pty Ltd, the Artificial Intelligence and Genomics to Predict Cancer Treatment Project, will receive $2.6 million under the fifth round of the CRC-P Program and has attracted $6.4 million of cash and in kind contributions from industry partners.
In addition, the Implementing Intelligent Automated Reporting in Radiology Practice Project, led by Max Kelsen has secured $1.1 million in Commonwealth support for the current round, backed by $3.8 million in cash and in-kind contributions from industry partners.
Assistant Minister for Science, Jobs and Innovation Zed Seselja says the CRC-P Program plays a critical part in the Government’s commitment to innovation.
With one in four Australians receiving a cancer diagnosis in their lifetime, the CRC-Ps announcement will have a positive impact on countless Australians.
“The CRC-P Program will also help businesses, industries and research organisations to work together on short-term projects to develop practical solutions to challenges in key industry sectors,” explains Assistant Minister Seselja.
Federal Member for Brisbane, Trevor Evans, says the Coalition Government’s support for Innovation in Brisbane is integral for local jobs.
“Supporting these leading research projects will not only have wide-ranging benefits for all Australians at the completion of research, but will also keep local high-level jobs in Brisbane, boosting the local economy.”
“I look forward to seeing Brisbane innovation improving lives across the country and making cancer diagnosis faster, more affordable and more accurate,” says Mr Evans.